Life Science REIT PLC (LABS) - Total Assets
Based on the latest financial reports, Life Science REIT PLC (LABS) holds total assets worth GBX374.95 Million GBX (≈ $45.62K USD) as of June 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See net assets of Life Science REIT PLC for net asset value and shareholders' equity analysis.
Life Science REIT PLC - Total Assets Trend (2021–2024)
This chart illustrates how Life Science REIT PLC's total assets have evolved over time, based on quarterly financial data.
Life Science REIT PLC - Asset Composition Analysis
Current Asset Composition (December 2024)
Life Science REIT PLC's total assets of GBX374.95 Million consist of 1.4% current assets and 98.6% non-current assets.
| Asset Category | Amount (GBX) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | GBX0.00 | 1.4% |
| Accounts Receivable | GBX7.84 Million | 2.0% |
| Inventory | GBX0.00 | 0.0% |
| Property, Plant & Equipment | GBX0.00 | 0.0% |
| Intangible Assets | GBX0.00 | 0.0% |
| Goodwill | GBX0.00 | 0.0% |
Asset Composition Trend (2021–2024)
This chart illustrates how Life Science REIT PLC's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see market value of Life Science REIT PLC.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Life Science REIT PLC's current assets represent 1.4% of total assets in 2024, a decrease from 46.2% in 2021.
- Cash Position: Cash and equivalents constituted 1.4% of total assets in 2024, down from 45.9% in 2021.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2021.
- Asset Diversification: The largest asset category is accounts receivable at 2.0% of total assets.
Life Science REIT PLC Competitors by Total Assets
Key competitors of Life Science REIT PLC based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Healthco Healthcare and Wellness REIT
AU:HCW
|
Australia | AU$1.18 Billion |
|
Aedifica
BR:AED
|
Belgium | €6.48 Billion |
|
Cofinimmo SA
BR:COFB
|
Belgium | €6.42 Billion |
|
Care Property Invest NV
BR:CPINV
|
Belgium | €1.39 Billion |
|
Chartwell Retirement Residences
TO:CSH-UN
|
Canada | CA$5.16 Billion |
|
NorthWest Healthcare Properties Real Estate Investment Trust
TO:NWH-UN
|
Canada | CA$3.45 Billion |
|
Al Aqar Healthcare Reit
KLSE:5116
|
Malaysia | RM2.09 Billion |
|
Adriano Care SOCIMI SAU
MC:YADR
|
Spain | €268.30 Million |
Life Science REIT PLC - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.00 | 17.76 | 109.76 |
| Quick Ratio | 1.00 | -1.34 | -0.59 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | GBX5.00K | GBX23.84 Million | GBX165.42 Million |
Life Science REIT PLC - Advanced Valuation Insights
This section examines the relationship between Life Science REIT PLC's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.40 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | -2.3% |
| Total Assets | GBX401.19 Million |
| Market Capitalization | $1.84 Million USD |
Valuation Analysis
Below Book Valuation: The market values Life Science REIT PLC's assets below their book value (0.00x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Life Science REIT PLC's assets decreased by 2.3% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Life Science REIT PLC (2021–2024)
The table below shows the annual total assets of Life Science REIT PLC from 2021 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | GBX401.19 Million ≈ $48.81K |
-2.32% |
| 2023-12-31 | GBX410.70 Million ≈ $49.97K |
-8.29% |
| 2022-12-31 | GBX447.82 Million ≈ $54.49K |
+23.91% |
| 2021-12-31 | GBX361.40 Million ≈ $43.97K |
-- |
About Life Science REIT PLC
Life Science REIT plc is a specialist property business focused on the UK's growing life science sector. The Company's portfolio of assets is located across the Golden Triangle of research and development hubs in Oxford, Cambridge and London's Knowledge Quarter. Life Science REIT trades on the Main Market of the London Stock Exchange under the ticker LABS.